Luc Mainville

Luc Mainville is the founder of LUMA Capital LLC.
Current positions include Chief Financial Officer & Senior Vice President at ChitogenX, Inc. since 2018, President at LUMA Life, Inc. since 2015, and Chief Financial Officer & Senior Vice President at LSL Pharma Group, Inc. since 2023.
Former roles include President, Chief Executive Officer & Director at LAB Research, Inc. from 2006 to 2011; President & Chief Executive Officer at Neopharm Labs, Inc. from 2012 to 2015; Chairman at Power Tech Corp., Inc. from 2010 to 2011; Vice Chairman at BIOTECanada from 2010 to 2012; Chairman at BioAxone Therapeutic, Inc. in 2007; Chairman at Zucara Therapeutics, Inc. from 2017 to 2020; Director at Enobia Pharma, Inc.; Director at BANGI, Inc. from 2007 to 2008; Director at Alethia Biotherapeutics, Inc. from 2008 to 2011; Director at Acerus Pharmaceuticals Corp.
in 2018; Director at AAA Medic Montreal, Inc.; Senior Vice President at Correvio Pharma Corp.
in 2016; Chief Financial & Operating Officer at LAB International, Inc. from 2003 to 2006; CFO, Vice President-Finance & Administration at Waratah Pharmaceuticals, Inc. from 2000 to 2002; SVP & Partner-Corporate Finance Group at KPMG LLP from 1995 to 1998; Chief Financial Officer at SkyePharma Canada, Inc. from 1998 to 2001; CFO, Vice President-Finance & Administration at URRMA Biopharma, Inc. from 2002 to 2003; Chief Financial Officer & Senior Vice President at Valeo Pharma, Inc. from 2018 to 2023; Principal at Manitex Capital, Inc. Education includes an MBA from McGill University conferred in 1992 and an undergraduate degree from the University of Quebec conferred in 1987.